Amgen launches 2023 LabCentral Golden Ticket competition for innovative life science startups, awarding two startups with with lab space, amenities, and services.
Amgen launches 2020 LabCentral Golden Ticket competition for innovative life science startups, awarding two startups with with lab space, amenities, and services.
The Bristol Myers Squibb 2021 Golden Ticket Contest is a competition for the award of two Golden Tickets, which covers the cost of one 6-ft lab bench and one resident scientist fee for one year for a promising life science start-up.
AI Driven Bloodless Blood Tests Sean (Shunsuke) Matsuoka, Co-Founder & COO, GPx GPx: https://gpx.ai/
In an aging society, the number of heart failure patients is increasing, making the prevention of readmissions and reduction of medical costs critical issues. Remote monitoring using invasive implantable devices has proven effective in reducing heart failure readmissions, but its use remains limited.
To address this, GPx has developed an algorithm that non-invasively predicts signs of heart failure exacerbation. This algorithm was created using clinical trial data from monitoring 245 heart failure patients over 6 months to a year at eight facilities, including the Mayo Clinic in the U.S. The algorithm links digital biomarker data with vital blood tests (NT-proBNP and creatinine) to achieve high-precision prediction and early medical intervention.
Additionally, with a grant of 1.2 billion yen provided through AMED, we are collaborating with the National Cerebral and Cardiovascular Center (Dr. Chisato Izumi) to conduct a clinical trial involving 400 patients starting April 2025. The trial will be conducted at the National Cerebral and Cardiovascular Center, Kyoto University, Kobe University, and Kochi University.
Furthermore, at this year's MIT Japan Conference, we will unveil a groundbreaking point-of-care (POC) potassium testing device for the first time. At the conference, we aim to explore the feasibility of applying our technology to other conditions (such as kidney failure, pulmonary arterial hypertension, and cardio-oncology) and to assess the potential for providing algorithm-based services for heart failure patients within Japan.
"Slowing the aging process of aging by tweaking the body’s metabolism", Prof. Leonard P. Guarente, Novartis Professor of Biology, MIT & co-founder, Elysium Health
Lightning Talks featuring startups: Enbiotix, Ginkgo Bioworks, ManusBio, Glympse Bio, BioDevek, Asimov, and BioBuilder.